legislation: 112-hr-6190

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
112-hr-6190 112 hr 6190 Asthma Inhalers Relief Act of 2012 Environmental Protection 2012-07-25 2012-12-12 On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623). House Rep. Burgess, Michael C. [R-TX-26] TX R B001248 5 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013. Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012. Terminates this Act on August 1, 2013. 2022-03-01T06:10:55Z  

Links from other tables